SCHEMBL9458259

SCHEMBL9458259

CC(C)(Cc1c(Sc2ccccc2)c2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 10/20 0.72
CYP3A4 P08684 3/20 0.72
MAPT P10636 3/20 0.72
HSD17B10 Q99714 3/20 0.72
KDM4E B2RXH2 2/20 0.72
CYP1A2 P05177 2/20 0.72
CYP2C9 P11712 2/20 0.72
HPGD P15428 2/20 0.72
TDP1 Q9NUW8 2/20 0.72
TSHR P16473 2/20 0.72
CYP2C19 P33261 1/20 0.72
HIF1A Q16665 1/20 0.72
ALOX5AP P20292 7/20 0.60
PTGES O14684 5/20 0.60
ALOX5 P09917 2/20 0.60
MEN1 O00255 2/20 0.60
ALOX15 P16050 2/20 0.60
RECQL P46063 2/20 0.60
BLM P54132 2/20 0.60
KMT2A Q03164 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9458289 0.89 PTGES2 (0.75) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL9669124 0.88 PTGES2 (0.77) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL9457746 0.87 PTGES2 (0.80) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL9457636 0.85 MAPT (0.61) PTGES2CYP3A4MAPTHSD17B10KDM4E
Methane SCHEMBL9457803 0.84 MAPT (0.60) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL3252820 0.84 PTGES2 (1.00) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL29503039 0.84 PTGES2 (1.00) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL9457497 0.83 MAPT (0.59) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL9458293 0.81 MAPT (0.56) PTGES2CYP3A4MAPTHSD17B10KDM4E
SCHEMBL21465486 0.81 MEN1 (0.83) PTGES2CYP3A4MAPTHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0275667-B1 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES MERCK FROSST CANADA INC. (CA) 1992-03-18 EP claimed
US-5081138-A Antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1992-01-14 US claimed
EP-0275667-A1 3-hetero-substituted-N-benzyl-indoles MERCK FROSST CANADA INC. (CA) 1988-07-27 EP claimed
US-5225421-A Leukotriene antagonists; cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1993-07-06 US disclosed
EP-0275667-B1 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES MERCK FROSST CANADA INC. (CA) 1992-03-18 EP disclosed
US-5081138-A Antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1992-01-14 US disclosed
EP-0275667-A1 3-hetero-substituted-N-benzyl-indoles MERCK FROSST CANADA INC. (CA) 1988-07-27 EP disclosed